MX2009003728A - Nuevos derivados de alcaloides de isocarbostirilo que tienen actividades anti-proliferativas y anti-migratorias. - Google Patents

Nuevos derivados de alcaloides de isocarbostirilo que tienen actividades anti-proliferativas y anti-migratorias.

Info

Publication number
MX2009003728A
MX2009003728A MX2009003728A MX2009003728A MX2009003728A MX 2009003728 A MX2009003728 A MX 2009003728A MX 2009003728 A MX2009003728 A MX 2009003728A MX 2009003728 A MX2009003728 A MX 2009003728A MX 2009003728 A MX2009003728 A MX 2009003728A
Authority
MX
Mexico
Prior art keywords
proliferative
compounds
new
alkaloid derivatives
migratory activities
Prior art date
Application number
MX2009003728A
Other languages
English (en)
Inventor
Francis Darro
Robert Kiss
Eric Van Quaquebeke
Laurent Ingrassia
Laurent Van Den Hove
Lise Wlodarczak
Stephanie Thomas
Original Assignee
Unibioscreen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unibioscreen Sa filed Critical Unibioscreen Sa
Publication of MX2009003728A publication Critical patent/MX2009003728A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención se refiere a derivados de alcaloides nuevos que tienen actividades anti-proliferativas y anti-migratorias, en particular a compuesto de la fórmula (I) o (II), (ver fórmula (I) o (II)) estereoisómeros, tautómeros, racematos, profármacos, metabolitos de los mismos, o una sal y/o solvato farmacéuticamente aceptable de los mismos, en donde R1, R2, R3, R4, R5, R6, y R7 tienen el mismo significado como el que se define en las reivindicaciones. La presente invención también se refiere a un método para la preparación de los compuestos, a composiciones, en particular farmacéuticos, que comprenden tales compuestos, y a usos de tales compuestos en el tratamiento y profilaxis del cáncer.
MX2009003728A 2006-10-13 2007-10-12 Nuevos derivados de alcaloides de isocarbostirilo que tienen actividades anti-proliferativas y anti-migratorias. MX2009003728A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2006009922 2006-10-13
PCT/EP2007/060906 WO2008043846A2 (en) 2006-10-13 2007-10-12 New isocarbostyril alkaloid derivatives having anti-proliferative and anti-migratory activities

Publications (1)

Publication Number Publication Date
MX2009003728A true MX2009003728A (es) 2009-04-22

Family

ID=38255168

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003728A MX2009003728A (es) 2006-10-13 2007-10-12 Nuevos derivados de alcaloides de isocarbostirilo que tienen actividades anti-proliferativas y anti-migratorias.

Country Status (6)

Country Link
US (1) US20100076005A1 (es)
JP (1) JP2010505920A (es)
AU (1) AU2007306281A1 (es)
CA (1) CA2665605A1 (es)
MX (1) MX2009003728A (es)
WO (1) WO2008043846A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2934266B1 (fr) 2008-07-28 2010-09-17 Pf Medicament Derives azotes de la pancratistatine
CA2747565A1 (en) 2008-12-18 2010-06-24 Brock University Novel c-1analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation
WO2013006972A1 (en) 2011-07-11 2013-01-17 Mercure Claude Novel anti-cancer isocarbostyril alkaloid conjugates
US10763554B2 (en) * 2016-05-17 2020-09-01 Mitsubishi Electric Corporation Rechargeable battery protecting apparatus and power storage system
CN111840274A (zh) * 2019-04-25 2020-10-30 天津中医药大学 巴伐洛霉素a1在制备增强7-脱氧水仙环素的抗肝癌活性药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101102769B (zh) * 2005-01-14 2010-05-19 亚利桑那董事会，代表亚利桑那州立大学行事的亚利桑那州法人团体 纳斯他汀钠和相关化合物的合成

Also Published As

Publication number Publication date
US20100076005A1 (en) 2010-03-25
AU2007306281A1 (en) 2008-04-17
WO2008043846A2 (en) 2008-04-17
WO2008043846A3 (en) 2008-05-29
JP2010505920A (ja) 2010-02-25
CA2665605A1 (en) 2008-04-17

Similar Documents

Publication Publication Date Title
GEP20227433B (en) 2-amino-pyridine or 2-amino-pyrimidine derivatives as cyclin dependent kinase inhibitors
TW200833675A (en) Nicotinamide derivatives
MY150699A (en) 5-substituted quinazolinone derivatives as antitumor agents
WO2008121861A3 (en) Pyrazole and pyrrole compounds useful in treating iron disorders
MY148634A (en) Pyridazinone derivatives
SI2134691T1 (sl) Derivati kvinolina kot PARP in TANK inhibitorji
EP2613782A4 (en) INDAZOLE DERIVATIVES AS INHIBITORS OF THE ERK PATHWAY
MY145795A (en) Pyrazoline compounds
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
TW200633698A (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
MX2009005264A (es) Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos.
NO20081554L (no) Isoindollmidforbindelser og sammensetninger omfattende samme, og anvendelse derav
MX2012007273A (es) Pteridinonas como inhibidores de la quinasa tipo polo.
MX2009012168A (es) Derivados de pirrolopiridina y su uso como inhibidores de la enzima que escinde la proteina precursora de amiloide por el sitio beta.
MX2009003157A (es) Pirazoliltienopiridinas terapeuticas.
GEP20084421B (en) Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
GEP20125456B (en) Azetidines as mek inhibitors for the treatment of proliferative diseases
PH12012502057A1 (en) Compounds for inhibiting mitotic progression
MY148538A (en) Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
MX2007013624A (es) Inhibidores de proteina cinasa.
TW200740776A (en) N-phenylbenzotriazolyl c-kit inhibitors
MX2010001486A (es) Derivados de tetrahidropiridin carboxamida como antagonistas de trpvl.
MX2010009022A (es) Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
MX2010005649A (es) Compuestos novedosos como ligandos del receptor canabinoide y sus usos.
GEP20125389B (en) Substituted pyrazole and triazole compounds as ksp inhibitors

Legal Events

Date Code Title Description
HH Correction or change in general